28.00
28.00 (0.68%)
As of Mar 06, 2024
Ambrx Biopharma Inc. [AMAM]
Source:
Company Overview
Ambrx Biopharma Inc. is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics, or EPBs, using our proprietary expanded genetic code technology platform that allows us to incorporate, in a site-specific manner, synthetic amino acids, or SAAs, into proteins within living cells.
Country | United States |
Headquarters | la jolla, california |
Phone Number | (858) 875-2400 |
Industry | |
CEO | Daniel J. O’Connor |
Website | www.clinicaltrials.gov |